Most medtech companies can’t seamlessly exchange product information between in-country and global regulatory assurance teams, according to the 2023 Regulatory Benchmark Report from Veeva MedTech. Without a standardized and consistent way to share documents globally, organizations can’t ensure the reliability or accuracy of product information across markets. This increases compliance risk.
Featured Posts
In an interview with Med Ad News, Leo Tarkovsky, chief commercial officer at Fingerpaint Group discusses the transformation in what clients want and need with respect to their partners, along with the evolving expectations of healthcare companies.
This latest collaboration aims to further enhance The Bloc’s presence in the U.K. marketing and medical communications market, building on its leadership position in global health communication.
These appointments follow a year where Ogilvy Health saw its integrated solutions including brand development, strategy, experience and innovation, PR and influence, medical education, and market access, winning accolades at some of the industry’s most prominent award shows totaling over 160 creative awards.
Fingerpaint Marketing is on an impressive course of growth. Mark Willmann, president of marketing services at Fingerpaint Group, talks to Med Ad News about the agency’s growth trajectory and how their mantra has been the foundation for their success.
Eli Lilly’s Mounjaro is being launched in Britain this week, two pharmacy companies said on Wednesday, making the UK the fourth European country to introduce the highly anticipated obesity drug.
Global animal health leader adopts Veeva Vault Clinical and Veeva Vault RIM for greater efficiency, visibility, and speed.
Fitbit and Quest Diagnostics have announced a collaboration to study the potential of wearable devices to improve metabolic health, which influences the risk of developing several diseases, including diabetes and heart disease.
As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors. There are the usual suspects like evolving provider models, the continued transition to value-based care, and pharma and biotech companies’ increased investment in “access,” but there are two trends that are at the top of the “what we’re watching” list for 2024.
PERIOD., a global youth-powered non-profit, launched the typeface, Sans Period, to provide crucial period education for kids who may no longer get it in school.